Lmr Partners LLP Biomea Fusion, Inc. Transaction History
Lmr Partners LLP
- $10.5 Billion
- Q2 2025
A detailed history of Lmr Partners LLP transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 35,100 shares of BMEA stock, worth $56,160. This represents 0.01% of its overall portfolio holdings.
Number of Shares
35,100Holding current value
$56,160% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BMEA
# of Institutions
98Shares Held
23.1MCall Options Held
1.08MPut Options Held
359K-
Heights Capital Management, Inc San Francisco, CA3.84MShares$6.14 Million1.84% of portfolio
-
Cormorant Asset Management, LP Boston, MA3.57MShares$5.71 Million0.65% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$3.75 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY2.05MShares$3.28 Million1.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$3.01 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $46.9M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...